An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
[HTML][HTML] Post-acute COVID-19 syndrome
A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
X Wu, X Liu, Y Zhou, H Yu, R Li, Q Zhan… - The Lancet …, 2021 - thelancet.com
Background The consequences of COVID-19 in those who recover from acute infection
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …
requiring hospitalisation have yet to be clearly defined. We aimed to describe the temporal …
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
O Moreno-Pérez, E Merino, JM Leon-Ramirez… - Journal of Infection, 2021 - Elsevier
Objectives This study aims to analyze the incidence of Post-acute COVID-19 syndrome
(PCS) and its components, and to evaluate the acute infection phase associated risk factors …
(PCS) and its components, and to evaluate the acute infection phase associated risk factors …
Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms
The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
Persistent post–COVID-19 interstitial lung disease. An observational study of corticosteroid treatment
KJ Myall, B Mukherjee, AM Castanheira… - Annals of the …, 2021 - atsjournals.org
Rationale: The natural history of recovery from severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) remains unknown. Because fibrosis with persistent …
coronavirus 2 (SARS-CoV-2) remains unknown. Because fibrosis with persistent …
[HTML][HTML] Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study
SA Guler, L Ebner, C Aubry-Beigelman… - European respiratory …, 2021 - Eur Respiratory Soc
Background The infectious coronavirus disease 2019 (COVID-19) pandemic is an ongoing
global healthcare challenge. Up to one-third of hospitalised patients develop severe …
global healthcare challenge. Up to one-third of hospitalised patients develop severe …
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Objective To assess medium-term organ impairment in symptomatic individuals following
recovery from acute SARS-CoV-2 infection. Design Baseline findings from a prospective …
recovery from acute SARS-CoV-2 infection. Design Baseline findings from a prospective …
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort
DT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner… - Thorax, 2021 - thorax.bmj.com
The longer-term consequences of SARS-CoV-2 infection are uncertain. Consecutive
patients hospitalised with COVID-19 were prospectively recruited to this observational study …
patients hospitalised with COVID-19 were prospectively recruited to this observational study …